EP3052098
ENZALUTAMIDE IN COMBINATION WITH AFURESERTIB FOR THE TREATMENT OF PROSTATE CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.10.2014EP published:
2.12.2020EP application number:
14790344.7
EPO information:
European Patent Register
Max expiry date:
30.9.2034
Title:
ENZALUTAMIDE IN COMBINATION WITH AFURESERTIB FOR THE TREATMENT OF PROSTATE CANCER
Timeline
Today
1.10.2014EP application
2.12.2020EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
CORNFELD, Mark J.Address:
Collegeville, Pennsylvania 19426, US
Name:
KUMAR, RakeshAddress:
Collegeville, Pennsylvania 19426, US
Name:
MORRIS, Shannon RenaeAddress:
Research Triangle Park, North Carolina 27709, US
Priority
Number:
201361885053 PDate:
1.10.2013Country:
US
Number:
201461935404 PDate:
4.2.2014Country:
US
Classification
Categories:
A61K 31/4155, A61K 31/4166, A61K 45/06, A61K 31/58, A61P 35/00, A61P 35/02